how glp 1 medications are changing consumer behavior Is GLP-1 Choices for Good? Chart: 1 in 8 Americans

We analyzed data from over 300,000 vehicle owners we surveyed in 2024, covering models that came out between 2000 and 2023

Drug interactions are usually temporary and manageable

However, GLP-1 receptor agonists are designed to stick around longer in your bloodstream than naturally-produced GLP-1

With these points in mind, we undertook a broad assessment of published clinical data, curating the body weight loss (% from baseline), glycosylated hemoglobin levels (HbA1c), and nausea responses (% patients reporting) from the SUSTAIN 3, SUSTAIN 7, SCALE Diabetes, SURPASS 2, and STEP 2 trials (17, 22, 64, 66, 67) ( Figures 1AC )

nausea constipation diarrhea decreased appetite bloating fatigue Most side effects improve gradually as the body adjusts

Patients often report feeling a difference in energy and mental clarity within hours of an infusion, consistent with the restoration of mitochondrial redox status